SCHEMBL16619633

SCHEMBL16619633

Cc1nc(-c2ccc(C(O[Si](C)(C)C(C)(C)C)C3CCC(Cc4ccc(C(=O)N(C)Cc5cccnc5)cc4)N3C(=O)OC(C)(C)C)cn2)no1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 4/20 0.35
ACACB O00763 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
TLR8 Q9NR97 1/20 0.32
TLR7 Q9NYK1 1/20 0.32
CNR2 P34972 1/20 0.31
GRM5 P41594 1/20 0.31
PDK1 Q15118 6/20 0.31
PDK2 Q15119 3/20 0.31
PDK3 Q15120 3/20 0.31
PDK4 Q16654 3/20 0.31
TNF P01375 1/20 0.31
MAPK1 P28482 1/20 0.31
NOD2 Q9HC29 1/20 0.31
NOD1 Q9Y239 1/20 0.31
JAK1 P23458 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16619634 1.00 GPR119 (0.35) GPR119ACACBNPC1RAB9ATLR8
SCHEMBL16629792 0.88 ACACB (0.34) GPR119ACACBNPC1RAB9AGRM5
SCHEMBL17986608 0.88 ACACB (0.34) GPR119ACACBNPC1RAB9AGRM5
SCHEMBL16629791 0.88 ACACB (0.35) GPR119ACACBNPC1RAB9AGRM5
SCHEMBL16619094 0.87 ACACB (0.36) GPR119ACACBNPC1RAB9AGRM5
SCHEMBL17986538 0.87 ACACB (0.36) GPR119ACACBNPC1RAB9AGRM5
SCHEMBL16629797 0.86 ACACB (0.35) GPR119ACACBNPC1RAB9AGRM5
SCHEMBL16619630 0.86 ACACB (0.32) GPR119ACACB
SCHEMBL16630571 0.86 JAK2 (0.37) GPR119ACACBGRM5PDK1PDK2
SCHEMBL17986587 0.84 ACACB (0.33) GPR119ACACBNPC1RAB9AGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052099-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2016-08-10 EP disclosed
WO-2015050798-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2015-04-09 WO disclosed